Tokai Carbon Korea Co. Ltd (064760)
KOSDAQ · Korea · prices in KRW · close of 19 Oct 2026
Key indicators
| Last close | KRW 234,500.00 |
|---|---|
| 52-week range | 135,757.17 – 348,500.00 |
| Return, 1 month / 3 months | −10.2% / −0.8% |
| Return, 1 year / 3 years | +35.3% / +150.9% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 84.0% |
| Worst drawdown (1 year) | -60.3% |
| Average daily value traded | 17,705.09M KRW |
| Dividend yield | 0.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Tokai Carbon Korea makes specialty graphite products for industrial and electronics customers. The company produces fine-grained graphite components used in equipment for making semiconductors and light-emitting diodes, along with graphite materials for high-temperature furnaces and other industrial applications. It serves manufacturers in Korea and export markets from its base in Korea, and it operates as part of the wider Tokai Carbon group of Japan.
The shares are listed on the KOSDAQ in Korea under the code 064760, and the price on this page is in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Tokai Carbon Korea Co. Ltd (064760) trades on the KOSDAQ in Korea. It last closed at KRW 234,500.00 on 19 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 425 of 1,830 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 35.3% and over the last three months it fell 0.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on KOSDAQ
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 79 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -1.1% | ||
| From 52-week high | -32.7% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.8% | ||
| 6-month return | -2.7% | ||
| 12-month return, skipping the last month | 50.6% | ||
| Risk (lower is better) | 37 · Weak | Volatile, with deep drawdowns. | |
| Volatility (1 year) | 84.0% | ||
| Worst drawdown (1 year) | -60.3% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 17,705.09M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Risk (lower is better): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −19.3% |
|---|---|
| 1 month | −10.2% |
| 3 months | −0.8% |
| 6 months | −2.7% |
| 1 year | +35.3% |
| 3 years | +150.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 250,382.00 / 237,148.64 |
|---|---|
| Golden / death cross (60 days) | Golden, 10 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 20,334.28 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Dec 2025 | KRW 1,430.0000 |
| 27 Dec 2024 | KRW 1,410.0000 |
| 27 Dec 2023 | KRW 1,200.0000 |
| 28 Dec 2022 | KRW 1,700.0000 |
| 29 Dec 2021 | KRW 1,430.0000 |
| 29 Dec 2020 | KRW 1,100.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on KOSDAQ; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.